Policy Comments
The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.
Letter thanking President Biden for the increase in funding for the Agency for Healthcare Research and Quality (AHRQ) in its staffing and administrative support for the U.S. Preventive Services Task Force (USPSTF) in his Fiscal Year 2024 budget proposal.
Letter to HHS in response to the Advancing Interoperability and Improving Prior Authorization Proposed Rule offering comments and recommendations addressing specific provisions in the proposed rule.
Letter in response to the Senate HELP committee's RFI on the growing health care workforce shortage urging the committee to consider the Palliative Care and Hospice Education and Training Act (PCHETA) as it seeks to address interdisciplinary workforce shortages for the care of patients with serious illness.
Supporting and Protecting the Medicaid Program
Recommendations for protecting patients’ access to care as the Medicaid continuous coverage requirements end.
Letter in response to the Senate HELP committee's RFI emphasizing the importance of including the patient perspective when considering the impact of the growing health care workforce shortages.
Letter outlining how the Affordable Care Act outlines has improved access to affordable healthcare and highlights ways to improve affordability.
Letter urging Congress to ensure that regulators at CMS create specific opportunities for patient advocates to participate in the regulatory process.
Letter to Congress requesting an increase in federal funding for domestic and global antimicrobial resistance (AMR) programs through the appropriations process.
Letter urging any efforts to change Medicaid’s current financing structure or add any barriers to coverage be rejected.